Common Contracts
2 similar Joint Research Agreement contracts
Joint Research with View to Developing Regenerative Medicine Product for Type 1 Diabetes by Producing Pancreatic Beta Cells Through Direct Reprogramming of Bone Marrow-Derived Mesenchymal Stem CellsJoint Research Agreement • January 24th, 2020
Type 1 diabetes is a potentially life-threatening autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells, and people with type 1 diabetes require lifelong treatment with insulin. Globally, around 5% of all diabetes patients are type 1 diabetes, and while the disease is most common in younger people it occurs across a wide range of age groups1,2. In 2017, there are about 80,000 patients suffering from type 1 diabetes3.
Joint Research with View to Developing Regenerative Medicine Product for Type 1 Diabetes by Producing Pancreatic Beta Cells Through Direct Reprogramming of Bone Marrow-Derived Mesenchymal Stem CellsJoint Research Agreement • January 23rd, 2020
Type 1 diabetes is a potentially life-threatening autoimmune disease characterized by the destruction of insulin-producing pancreatic beta cells, and people with type 1 diabetes require lifelong treatment with insulin. Globally, around 5% of all diabetes patients are type 1 diabetes, and while the disease is most common in younger people it occurs across a wide range of age groups1,2. In 2017, there are about 80,000 patients suffering from type 1 diabetes3.
